Cargando…
Advances Of Chimeric Antigen Receptor T Cell Therapy In Ovarian Cancer
Ovarian cancer, as a common gynecological tumor, is currently recognized as the most lethal gynecological malignancy. In addition to conventional treatment methods such as surgery, radiotherapy and chemotherapy, adoptive immunotherapy represented by modified immune cells also shows good curative eff...
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Dove
2019
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6777428/ https://www.ncbi.nlm.nih.gov/pubmed/31686857 http://dx.doi.org/10.2147/OTT.S203550 |